全面的UV-LED验证与特定生物体剂量确定.
Hannah Ray1, Ariel J Atkinson1
1Southern Nevada Water Authority, River Mountain Water Treatment Facility, 1229 Burkholder Blvd, Henderson, Nevada 89015, United States.
Environmental science & technology
|February 20, 2026
概括
这项研究验证了用于饮用水消毒的UV-LED反应器,成功地证明了有效的Legionella pneumophila控制. 经过验证的方法确保了可靠的消毒性能,为在水处理中更广泛采用UV-LED技术铺平了道路.
科学领域:
- 环境工程 环境工程
- 微生物学 微生物学
- 水处理技术水处理技术
背景情况:
- 紫外线发光二极管 (UV-LED) 技术为饮用水消毒提供了一个有希望的替代方案.
- 缺乏经过验证的UV-LED反应器和协议,阻碍了其广泛应用.
- 肺炎杆菌是水中传播的重要病原体,需要有效的消毒策略.
研究的目的:
- 为了验证美洲第一个全尺寸的UV-LED反应器用于Legionella pneumophila消毒.
- 开发和验证适用于L. pneumophila的降低等效剂量 (RED) 监测方程.
- 在各种操作条件下评估UV-LED反应器的性能.
主要方法:
- 在市政井上安装和测试一个全尺寸的UV-LED280反应器.
- 使用MS2和T1UV替代品设计和执行实验室和全面验证测试,按照USEPA的指导.
- 操作参数的变化,包括流量,紫外线发射率 (UVT280) 和功率水平,以评估反应堆性能.
主要成果:
- 计算剂量方法成功生成了L. pneumophila特定的紫外线强度设定值.
- 开发了一种经过验证的RED监测方程,其中包含了L. pneumophila紫外线敏感度因子,从而减少了RED过高/低估.
- 验证的L. pneumophila REDs在3.7-47mJ/cm2之间,即使在极端条件下,也始终超过治疗要求.
结论:
- 该研究成功地展示了UV-LED280反应器和L. pneumophila消毒的强有力的验证方法.
- 开发的RED监测方程提供了准确可靠的消毒性能评估.
- 对UV-LED技术的具体指导将进一步支持其在水利设施中的实施和监管接受.
更多相关视频
06:31Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
9.2K
05:13LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
Published on: January 24, 2025
850
相关概念视频
Dose Size and Dosing Frequency: Determination Methods
374
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
374
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
284
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
284
